Cebranopadol, a Novel First-in-Class Analgesic Drug Candidate: First Experience With Cancer-Related Pain for up to 26 Weeks - Concepedia

Concepedia

Publication | Open Access

Cebranopadol, a Novel First-in-Class Analgesic Drug Candidate: First Experience With Cancer-Related Pain for up to 26 Weeks

DOI Full Paper Access

31

Citations

14

References

2019

Year

E. Dietlind Koch, Sofia Kapanadze, Marie‐Henriette Eerdekens, Georg Kralidis, J. Létal, Ingo Sabatschus, Sam H. Ahmedzai

Journal of Pain and Symptom Management

Health SciencesPain MedicineMedicinePostoperative Pain ManagementCancer-related PainCancer PainPharmacotherapyPain ManagementFirst ExperienceAnesthesiaPharmacologyAnalgesicsDrug DiscoveryAnesthesiologyPain Research

References

	Year	Citations

Page 1

Page 1